Biotricity Total Debt vs. Market Capitalization

BTCY Stock  USD 1.25  0.05  3.85%   
Based on the key profitability measurements obtained from Biotricity's financial statements, Biotricity may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in June. Profitability indicators assess Biotricity's ability to earn profits and add value for shareholders. Price To Sales Ratio is likely to drop to 0.46 in 2024. Days Sales Outstanding is likely to drop to 74.99 in 2024. At this time, Biotricity's Income Tax Expense is fairly stable compared to the past year. Income Quality is likely to rise to 0.41 in 2024, whereas Accumulated Other Comprehensive Income is likely to drop (144.4 K) in 2024.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.330.51
Way Down
Slightly volatile
For Biotricity profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Biotricity to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Biotricity utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Biotricity's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Biotricity over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.
Is Biotricity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biotricity. If investors know Biotricity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biotricity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.75)
Revenue Per Share
1.319
Quarterly Revenue Growth
0.209
Return On Assets
(0.95)
Return On Equity
(41.01)
The market value of Biotricity is measured differently than its book value, which is the value of Biotricity that is recorded on the company's balance sheet. Investors also form their own opinion of Biotricity's value that differs from its market value or its book value, called intrinsic value, which is Biotricity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biotricity's market value can be influenced by many factors that don't directly affect Biotricity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biotricity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biotricity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biotricity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Biotricity Market Capitalization vs. Total Debt Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Biotricity's current stock value. Our valuation model uses many indicators to compare Biotricity value to that of its competitors to determine the firm's financial worth.
Biotricity is the top company in total debt category among related companies. It is number one stock in market capitalization category among related companies creating about  0.61  of Market Capitalization per Total Debt. The ratio of Total Debt to Market Capitalization for Biotricity is roughly  1.65 . At this time, Biotricity's Market Cap is fairly stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Biotricity by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Biotricity's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biotricity's earnings, one of the primary drivers of an investment's value.

Biotricity Total Debt vs. Competition

Biotricity is the top company in total debt category among related companies. Total debt of Health Care industry is currently estimated at about 1.64 Billion. Biotricity claims roughly 19.55 Million in total debt contributing just under 2% to equities under Health Care industry.
Total debt  Revenue  Workforce  Valuation  Capitalization

Biotricity Market Capitalization vs. Total Debt

Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Biotricity

Total Debt

 = 

Bonds

+

Notes

 = 
19.55 M
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

Biotricity

Market Cap

 = 

Shares Outstanding

X

Share Price

 = 
11.84 M
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.

Biotricity Market Capitalization vs Competition

Biotricity is number one stock in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 1.37 Billion. Biotricity maintains roughly 11.84 Million in market capitalization contributing less than 1% to equities under Health Care industry.
Capitalization  Total debt  Workforce  Valuation  Revenue

Biotricity Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Biotricity, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Biotricity will eventually generate negative long term returns. The profitability progress is the general direction of Biotricity's change in net profit over the period of time. It can combine multiple indicators of Biotricity, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-137.5 K-144.4 K
Operating Income-14 M-13.3 M
Income Before Tax-16.8 M-16 M
Total Other Income Expense Net-599.2 K-569.3 K
Net Loss-16.8 M-16 M
Income Tax Expense2.8 M2.9 M
Net Loss-16.8 M-17.6 M
Net Loss-27.2 M-25.8 M
Net Interest Income-2.3 M-2.4 M
Non Operating Income Net Other335 K297.8 K
Change To Netincome5.5 M3.4 M
Net Loss(1.42)(1.50)
Income Quality 0.38  0.41 
Net Income Per E B T 0.00  0.00 

Biotricity Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Biotricity. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Biotricity position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Biotricity's important profitability drivers and their relationship over time.

Use Biotricity in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biotricity position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotricity will appreciate offsetting losses from the drop in the long position's value.

Biotricity Pair Trading

Biotricity Pair Trading Analysis

The ability to find closely correlated positions to Biotricity could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biotricity when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biotricity - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biotricity to buy it.
The correlation of Biotricity is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biotricity moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biotricity moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biotricity can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Biotricity position

In addition to having Biotricity in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Sector ETFs Thematic Idea Now

Sector ETFs
Sector ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Sector ETFs theme has 421 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sector ETFs Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Biotricity offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biotricity's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biotricity Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biotricity Stock:
Check out Trending Equities.
For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.
Note that the Biotricity information on this page should be used as a complementary analysis to other Biotricity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Complementary Tools for Biotricity Stock analysis

When running Biotricity's price analysis, check to measure Biotricity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotricity is operating at the current time. Most of Biotricity's value examination focuses on studying past and present price action to predict the probability of Biotricity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotricity's price. Additionally, you may evaluate how the addition of Biotricity to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
To fully project Biotricity's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Biotricity at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Biotricity's income statement, its balance sheet, and the statement of cash flows.
Potential Biotricity investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Biotricity investors may work on each financial statement separately, they are all related. The changes in Biotricity's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Biotricity's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.